Alkermes - 35 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits and dividends. The latest closing stock price for Alkermes as of January 21, 2026 is 33.85.

The all-time high Alkermes stock closing price was 98.06 on March 01, 2000.
The Alkermes 52-week high stock price is 36.45, which is 7.7% above the current share price.
The Alkermes 52-week low stock price is 25.16, which is 25.7% below the current share price.
The average Alkermes stock price for the last 52 weeks is 30.15.

Alkermes Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	30.1154	28.2600	33.8500	28.0000	33.8500	20.98%
2025	30.0938	28.7500	36.0000	26.1300	27.9800	-2.71%
2024	27.0795	28.6200	32.5600	23.0100	28.7600	3.68%
2023	28.1991	25.8700	33.6300	23.3700	27.7400	6.16%
2022	25.8508	24.1500	31.8700	21.9400	26.1300	12.34%
2021	24.3681	19.7400	32.1300	18.2100	23.2600	16.59%
2020	17.6379	19.7600	22.1000	13.0600	19.9500	-2.21%
2019	25.4201	29.1100	37.3300	17.2900	20.4000	-30.87%
2018	45.9912	55.2200	67.2600	27.9400	29.5100	-46.08%
2017	54.8202	56.1000	61.6600	47.6900	54.7300	-1.53%
2016	45.4797	74.8300	75.2700	29.0500	55.5800	-29.98%
2015	66.3881	58.2400	80.1400	55.0800	79.3800	35.55%
2014	47.3686	40.2400	58.8800	40.0700	58.5600	44.02%
2013	30.2679	19.2800	41.1200	19.2800	40.6600	119.55%
2012	18.1843	17.3400	20.8800	15.1200	18.5200	6.68%
2011	15.4303	12.5500	19.5200	12.1400	17.3600	41.37%
2010	12.4458	9.7100	15.9200	9.6900	12.2800	30.50%
2009	9.6078	10.7100	13.1300	7.5600	9.4100	-11.64%
2008	12.2138	15.1000	16.8900	6.1000	10.6500	-31.69%
2007	15.7875	13.0900	18.5600	12.7600	15.5900	16.60%
2006	18.9789	20.5200	26.7100	13.1800	13.3700	-30.07%
2005	14.4017	14.0100	19.6600	10.0100	19.1200	35.70%
2004	13.3926	13.9700	16.8600	8.5100	14.0900	4.37%
2003	11.0879	6.6600	15.5600	6.5200	13.5000	115.31%
2002	15.1027	25.7500	30.3400	3.7800	6.2700	-76.21%
2001	26.8796	27.6250	37.1000	17.5000	26.3600	-15.98%
2000	41.5579	25.5000	98.0625	23.6250	31.3750	27.74%
1999	15.7495	11.6875	26.8125	11.4375	24.5625	121.41%
1998	9.9983	9.9375	13.3750	5.3125	11.0938	11.64%
1997	9.5159	11.1875	14.8125	5.1875	9.9375	-14.52%
1996	6.2354	3.7500	12.1250	3.7500	11.6250	192.91%
1995	2.4000	1.0313	4.3125	1.0000	3.9688	273.53%
1994	2.4714	3.6875	4.5000	1.0625	1.0625	-69.64%
1993	4.1401	4.5000	5.5000	3.1250	3.5000	-17.65%
1992	6.0672	9.0000	14.1875	2.7500	4.2500	-52.78%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$5.242B	$1.558B
Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major therapeutic areas. Alkermes holds a diversified product portfolio and a promising pipeline of candidates targeting major central nervous system (CNS) disorders including schizophrenia, depression, addiction and multiple sclerosis. Alkermes derives revenues on net sales of its proprietary products: Vivitrol & Aristada, and manufacturing and/or royalty revenues on net sales of products commercialized by the company's partners. These include Risperdal Consta, Invega Sustenna/Xeplion, Invega Trinza/Trevicta, Ampyra/Fampyra and Bydureon. Interesting late-stage candidate in the company's pipeline include nemvaleukin alfa developed for treating advanced solid tumors. Its proprietary drugs are Vivitrol & Aristada.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$278.977B	19.68
Amgen (AMGN)	United States	$178.237B	15.14
Gilead Sciences (GILD)	United States	$154.018B	15.16
Vertex Pharmaceuticals (VRTX)	United States	$112.164B	28.88
Bristol Myers Squibb (BMY)	United States	$110.379B	8.27
GSK (GSK)	United Kingdom	$97.130B	10.76
Regeneron Pharmaceuticals (REGN)	United States	$77.120B	20.00
CSL (CSLLY)	Australia	$57.549B	0.00
Argenex SE (ARGX)	Netherlands	$50.103B	61.90
Alnylam Pharmaceuticals (ALNY)	United States	$46.970B	1545.78
Insmed (INSM)	United States	$34.872B	0.00
Biogen (BIIB)	United States	$24.262B	9.88
BioNTech SE (BNTX)	Germany	$23.770B	0.00
Royalty Pharma (RPRX)	United States	$22.564B	8.65
Illumina (ILMN)	United States	$22.488B	33.76
Revolution Medicines (RVMD)	United States	$22.468B	0.00
Genmab (GNMSF)	Denmark	$21.829B	16.01
Incyte (INCY)	United States	$20.147B	19.29
Genmab (GMAB)	Denmark	$20.126B	15.14
Exact Sciences (EXAS)	United States	$19.529B	538.68
Moderna (MRNA)	United States	$16.802B	0.00
Roivant Sciences (ROIV)	United Kingdom	$15.982B	0.00
Guardant Health (GH)	United States	$14.478B	0.00
Ascendis Pharma (ASND)	Denmark	$13.361B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	24.50
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$12.026B	0.00
Exelixis (EXEL)	United States	$11.738B	18.79
QIAGEN (QGEN)	Netherlands	$11.710B	22.23
Avidity Biosciences (RNA)	United States	$10.919B	0.00
Bio-Techne Corp (TECH)	United States	$10.839B	40.44
BioMarin Pharmaceutical (BMRN)	United States	$10.818B	19.62
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.201B	39.78
Abivax SA (ABVX)	France	$9.322B	0.00
Axsome Therapeutics (AXSM)	United States	$9.301B	0.00
Repligen (RGEN)	United States	$9.194B	98.39
Arrowhead Pharmaceuticals (ARWR)	United States	$8.870B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$8.436B	30.33
Halozyme Therapeutics (HALO)	United States	$8.282B	13.24
Praxis Precision Medicines (PRAX)	United States	$8.165B	0.00
Krystal Biotech (KRYS)	United States	$7.969B	41.20
Cytokinetics (CYTK)	United States	$7.798B	0.00
Nuvalent (NUVL)	United States	$7.702B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.846B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
ImmunityBio (IBRX)	United States	$6.383B	0.00
Vaxcyte (PCVX)	United States	$6.221B	0.00
Belite Bio (BLTE)	United States	$6.003B	0.00
PTC Therapeutics (PTCT)	United States	$5.867B	7.97
Cogent Biosciences (COGT)	United States	$5.681B	0.00
Apogee Therapeutics (APGE)	United States	$5.605B	0.00
Structure Therapeutics (GPCR)	United States	$5.523B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.215B	134.55
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.014B	0.00
TG Therapeutics (TGTX)	United States	$4.912B	11.13
Kymera Therapeutics (KYMR)	United States	$4.903B	0.00
Celcuity (CELC)	United States	$4.877B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.723B	0.00
Immunovant (IMVT)	United States	$4.582B	0.00
Scholar Rock Holding (SRRK)	United States	$4.564B	0.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.475B	4.53
ACADIA Pharmaceuticals (ACAD)	United States	$4.448B	37.56
Anbio Biotechnology (NNNN)	Germany	$4.433B	0.00
Amicus Therapeutics (FOLD)	United States	$4.415B	357.75
CG Oncology (CGON)	United States	$4.412B	0.00
Legend Biotech (LEGN)	United States	$4.325B	0.00
ADMA Biologics Inc (ADMA)	United States	$4.186B	29.81
Arcellx (ACLX)	United States	$4.173B	0.00
GRAIL (GRAL)	United States	$3.949B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.869B	94.96
Viking Therapeutics (VKTX)	United States	$3.789B	0.00
Liquidia (LQDA)	United States	$3.424B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.295B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.206B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.169B	0.00
Beam Therapeutics (BEAM)	United States	$3.142B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.134B	0.00
Viridian Therapeutics (VRDN)	United States	$3.115B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.110B	91.18
Edgewise Therapeutics (EWTX)	United States	$3.042B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.011B	0.00
Vera Therapeutics (VERA)	United States	$2.866B	0.00
Disc Medicine (IRON)	United States	$2.794B	0.00
Erasca (ERAS)	United States	$2.783B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.728B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.725B	0.00
Alumis (ALMS)	United States	$2.720B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.619B	0.00
Spyre Therapeutics (SYRE)	United States	$2.617B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.590B	66.03
Denali Therapeutics (DNLI)	United States	$2.571B	0.00
Twist Bioscience (TWST)	United States	$2.552B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.527B	0.00
Travere Therapeutics (TVTX)	United States	$2.500B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.428B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.418B	6.56
Arcus Biosciences (RCUS)	United States	$2.370B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.310B	0.00
Recursion Pharmaceuticals (RXRX)	United States	$2.287B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.205B	0.00
Immunome (IMNM)	United States	$2.190B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.183B	0.00
Mesoblast (MESO)	Australia	$2.159B	0.00
Maze Therapeutics (MAZE)	United States	$2.134B	0.00
Zai Lab (ZLAB)	China	$2.117B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.068B	11.29
Nuvation Bio (NUVB)	United States	$2.060B	0.00
Dianthus Therapeutics (DNTH)	United States	$1.998B	0.00
MBX Biosciences (MBX)	United States	$1.937B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.927B	14.94
Dynavax Technologies (DVAX)	United States	$1.841B	54.07
Vericel (VCEL)	United States	$1.835B	151.21
Olema Pharmaceuticals (OLMA)	United States	$1.835B	0.00
Sionna Therapeutics (SION)	United States	$1.786B	0.00
Zymeworks (ZYME)	United States	$1.771B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.758B	0.00
MannKind (MNKD)	United States	$1.686B	54.90
Tango Therapeutics (TNGX)	United States	$1.685B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.684B	0.00
Upstream Bio (UPB)	United States	$1.675B	0.00
Celldex Therapeutics (CLDX)	United States	$1.671B	0.00
Mind Medicine (MindMed) (DFTX)	United States	$1.653B	0.00
Stoke Therapeutics (STOK)	United States	$1.640B	42.87
NeoGenomics (NEO)	United States	$1.635B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.599B	0.00
Rapt Therapeutics (RAPT)	United States	$1.595B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.591B	76.38
Tyra Biosciences (TYRA)	United States	$1.575B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.556B	0.00
Precigen (PGEN)	United States	$1.553B	0.00
Certara (CERT)	United States	$1.512B	27.91
Alvotech (ALVO)	Luxembourg	$1.495B	21.57
Intellia Therapeutics (NTLA)	United States	$1.486B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Fortrea Holdings (FTRE)	United States	$1.462B	31.02
NovoCure (NVCR)	Jersey	$1.457B	0.00
Kodiak Sciences (KOD)	United States	$1.413B	0.00
Nurix Therapeutics (NRIX)	United States	$1.402B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.398B	0.00
UniQure (QURE)	Netherlands	$1.395B	0.00
Pharvaris (PHVS)	Netherlands	$1.371B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.362B	0.00
Biohaven (BHVN)	United States	$1.342B	0.00
Trevi Therapeutics (TRVI)	United States	$1.336B	0.00
Novavax (NVAX)	United States	$1.332B	3.39
Oxford BioMedica (OXBDF)	United Kingdom	$1.309B	0.00
EyePoint (EYPT)	United States	$1.287B	0.00
AnaptysBio (ANAB)	United States	$1.279B	0.00
Pharming Group (PHAR)	Netherlands	$1.257B	0.00
AbCellera Biologics (ABCL)	Canada	$1.245B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.243B	0.00
Pharming Group (PHGUF)	Netherlands	$1.241B	185.00
Rapport Therapeutics (RAPP)	United States	$1.238B	0.00
Sana Biotechnology (SANA)	United States	$1.220B	0.00
Septerna (SEPN)	United States	$1.210B	0.00
Immatics (IMTX)	Germany	$1.200B	0.00
Castle Biosciences (CSTL)	United States	$1.193B	163.44
Palvella Therapeutics (PVLA)	United States	$1.160B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.132B	0.00
Zenas BioPharma (ZBIO)	United States	$1.121B	0.00
Inhibrx Biosciences (INBX)	United States	$1.060B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.049B	0.00
Nanobiotix S.A - (NBTX)	France	$1.016B	0.00
Compass Therapeutics (CMPX)	United States	$1.016B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$1.011B	0.00
Ventyx Biosciences (VTYX)	United States	$0.990B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.969B	0.00
Inventiva S.A (IVA)	France	$0.938B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
ArriVent BioPharma (AVBP)	United States	$0.919B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.917B	0.00
Bicara Therapeutics (BCAX)	United States	$0.916B	0.00
CytomX Therapeutics (CTMX)	United States	$0.910B	13.43
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
Urogen Pharma (URGN)	United States	$0.905B	0.00
YD Bio (YDES)		$0.843B	0.00
DBV Technologies S.A (DBVT)	France	$0.839B	0.00
Vir Biotechnology (VIR)	United States	$0.835B	0.00
Pacira BioSciences (PCRX)	United States	$0.830B	9.51
Geron (GERN)	United States	$0.830B	0.00
GH Research (GHRS)	Ireland	$0.819B	0.00
Arbutus Biopharma (ABUS)	United States	$0.809B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.808B	0.00
MiMedx (MDXG)	United States	$0.798B	14.18
Janux Therapeutics (JANX)	United States	$0.791B	0.00
MapLight Therapeutics (MPLT)	United States	$0.773B	0.00
Arvinas (ARVN)	United States	$0.773B	0.00
BioAge Labs (BIOA)	United States	$0.764B	0.00
Gyre Therapeutics (GYRE)	United States	$0.764B	99.12
Jade Biosciences (JBIO)	United States	$0.752B	0.00
Kura Oncology (KURA)	United States	$0.748B	0.00
Annexon (ANNX)	United States	$0.737B	0.00
REGENXBIO (RGNX)	United States	$0.714B	0.00
Astria Therapeutics (ATXS)	United States	$0.710B	0.00
Prime Medicine (PRME)	United States	$0.702B	0.00
Cytek Biosciences (CTKB)	United States	$0.679B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.642B	0.00
SELLAS Life Sciences (SLS)	United States	$0.615B	0.00
EnGene Holdings (ENGN)	Canada	$0.610B	0.00
LENZ Therapeutics (LENZ)	United States	$0.606B	0.00
Gossamer Bio (GOSS)	United States	$0.602B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.589B	0.00
Emergent Biosolutions (EBS)	United States	$0.583B	5.61
Evommune (EVMN)	United States	$0.580B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.574B	0.00
Keros Therapeutics (KROS)	United States	$0.561B	11.97
Replimune (REPL)	United States	$0.550B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.547B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.545B	0.00
CorMedix Inc (CRMD)	United States	$0.542B	5.02
Alto Neuroscience (ANRO)	United States	$0.541B	0.00
Design Therapeutics (DSGN)	United States	$0.538B	0.00
Myriad Genetics (MYGN)	United States	$0.529B	0.00
Invivyd (IVVD)	United States	$0.522B	0.00
Ocugen (OCGN)	United States	$0.522B	0.00
Prothena (PRTA)	Ireland	$0.498B	0.00
Niagen Bioscience (NAGE)	United States	$0.496B	38.81
Lexicon Pharmaceuticals (LXRX)	United States	$0.476B	0.00
Monopar Therapeutics (MNPR)	United States	$0.470B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.463B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.459B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.456B	0.00
NovaBridge Biosciences (NBP)	United States	$0.452B	0.00
Anavex Life Sciences (AVXL)	United States	$0.449B	0.00
Kamada (KMDA)	Israel	$0.449B	21.69
Verastem (VSTM)	United States	$0.444B	0.00
PureTech Health (PRTC)	United States	$0.438B	0.00
Solid Biosciences (SLDB)	United States	$0.438B	0.00
Absci (ABSI)	United States	$0.436B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.436B	0.00
Prima BioMed (IMMP)	Australia	$0.414B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.412B	0.00
PepGen (PEPG)	United States	$0.409B	0.00
Entrada Therapeutics (TRDA)	United States	$0.406B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.395B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.394B	0.00
Benitec Biopharma (BNTC)	United States	$0.394B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.386B	0.00
Forte Biosciences (FBRX)	United States	$0.381B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.378B	0.00
BGM Group (BGM)	China	$0.367B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.360B	0.00
Tectonic Therapeutic (TECX)	United States	$0.357B	0.00
Allogene Therapeutics (ALLO)	United States	$0.353B	0.00
Contineum Therapeutics (CTNM)	United States	$0.346B	0.00
Aardvark Therapeutics (AARD)	United States	$0.338B	0.00
AC Immune (ACIU)	Switzerland	$0.333B	0.00
Puma Biotechnology (PBYI)	United States	$0.333B	8.92
Zura Bio (ZURA)	United States	$0.326B	0.00
Candel Therapeutics (CADL)	United States	$0.325B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.324B	0.00
XOMA Royalty (XOMA)	United States	$0.323B	0.00
Amarin (AMRN)	Ireland	$0.322B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.321B	0.00
Aura Biosciences (AURA)	United States	$0.316B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.315B	0.00
Neumora Therapeutics (NMRA)	United States	$0.312B	0.00
Lifecore Biomedical (LFCR)	United States	$0.309B	0.00
Immuneering (IMRX)	United States	$0.309B	0.00
GENFIT S.A (GNFTY)	France	$0.299B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.295B	0.00
Climb Bio (CLYM)	United States	$0.295B	0.00
Abeona Therapeutics (ABEO)	United States	$0.288B	4.70
Palisade Bio (PALI)	United States	$0.282B	0.00
Shattuck Labs (STTK)	United States	$0.275B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.273B	0.00
Neurogene (NGNE)	United States	$0.271B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.269B	0.00
Rezolute (RZLT)	United States	$0.268B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.259B	0.00
Adherex Technologies (FENC)	United States	$0.252B	0.00
Jyong Biotech (MENS)	Taiwan	$0.248B	0.00
Immix Biopharma (IMMX)	United States	$0.244B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.228B	0.00
C4 Therapeutics (CCCC)	United States	$0.211B	0.00
Cabaletta Bio (CABA)	United States	$0.211B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.208B	0.00
Nuvectis Pharma (NVCT)	United States	$0.208B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.207B	0.00
Sagimet Biosciences (SGMT)	United States	$0.204B	0.00
Voyager Therapeutics (VYGR)	United States	$0.204B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.202B	0.00
Alector (ALEC)	United States	$0.200B	0.00
Editas Medicine (EDIT)	United States	$0.197B	0.00
Compugen (CGEN)	Israel	$0.195B	0.00
Crescent Biopharma (CBIO)	United States	$0.194B	0.00
Humacyte (HUMA)	United States	$0.191B	0.00
SAB Biotherapeutics (SABS)	United States	$0.191B	0.00
Quince Therapeutics (QNCX)	United States	$0.190B	0.00
Cardiff Oncology (CRDF)	United States	$0.189B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.188B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.188B	0.00
Coherus Oncology (CHRS)	United States	$0.187B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.183B	0.00
Vor Biopharma (VOR)		$0.183B	0.00
Alpha Teknova (TKNO)	United States	$0.180B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.177B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.171B	0.00
Innate Pharma S.A (IPHA)	France	$0.170B	0.00
Alps Group (ALPS)	United States	$0.168B	3.06
Rani Therapeutics Holdings (RANI)	United States	$0.165B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.164B	0.00
Opus Genetics (IRD)	United States	$0.156B	0.00
Codexis (CDXS)	United States	$0.145B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Nkarta (NKTX)	United States	$0.145B	0.00
Elicio Therapeutics (ELTX)	United States	$0.139B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.137B	6.67
Anika Therapeutics (ANIK)	United States	$0.136B	0.00
Seres Therapeutics (MCRB)	United States	$0.136B	0.00
Turn Therapeutics (TTRX)	United States	$0.136B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.135B	0.00
Spero Therapeutics (SPRO)	United States	$0.134B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.132B	0.00
Caribou Biosciences (CRBU)	United States	$0.130B	0.00
Actuate Therapeutics (ACTU)	United States	$0.129B	0.00
MaxCyte (MXCT)	United States	$0.129B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.129B	0.00
Sutro Biopharma (STRO)	United States	$0.127B	0.00
Fate Therapeutics (FATE)	United States	$0.127B	0.00
VTv Therapeutics (VTVT)	United States	$0.126B	0.00
Cognition Therapeutics (CGTX)	United States	$0.124B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.123B	0.00
Alpha Cognition (ACOG)	Canada	$0.121B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.117B	0.00
Agenus (AGEN)	United States	$0.115B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.113B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.113B	0.00
Repare Therapeutics (RPTX)	Canada	$0.111B	0.00
Tharimmune (THAR)	United States	$0.109B	0.00
Ovid Therapeutics (OVID)	United States	$0.108B	0.00
Fortress Biotech (FBIO)	United States	$0.108B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.105B	0.00
Genelux (GNLX)	United States	$0.104B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.104B	0.00
Seer (SEER)	United States	$0.104B	0.00
Tenax Therapeutics (TENX)	United States	$0.103B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.101B	0.00
Biomea Fusion (BMEA)	United States	$0.098B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.097B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Coya Therapeutics (COYA)	United States	$0.094B	0.00
EXoZymes (EXOZ)	United States	$0.093B	0.00
Scilex Holding (SCLX)	United States	$0.092B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.090B	0.00
Citius Oncology (CTOR)	United States	$0.089B	0.00
Adagene (ADAG)	China	$0.088B	0.00
MediciNova (MNOV)	United States	$0.083B	0.00
OKYO Pharma (OKYO)		$0.081B	0.00
CalciMedica (CALC)	United States	$0.081B	0.00
BioHarvest Sciences (BHST)	Canada	$0.079B	0.00
Pliant Therapeutics (PLRX)	United States	$0.079B	0.00
Immunic (IMUX)	United States	$0.078B	0.00
XBiotech (XBIT)	United States	$0.077B	0.00
Spruce Biosciences (SPRB)	United States	$0.076B	0.00
Adicet Bio (ACET)	United States	$0.076B	0.00
Annovis Bio (ANVS)	United States	$0.074B	0.00
Entera Bio (ENTX)	Israel	$0.072B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.072B	0.00
ImageneBio (IMA)	United States	$0.070B	0.00
Equillium (EQ)	United States	$0.070B	0.00
ATyr Pharma (ATYR)	United States	$0.069B	0.00
BeyondSpring (BYSI)	United States	$0.069B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.068B	0.00
InflaRx (IFRX)	Germany	$0.066B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.066B	0.00
CervoMed (CRVO)	United States	$0.065B	0.00
BioStem Technologies (BSEM)		$0.065B	4.52
TScan Therapeutics (TCRX)	United States	$0.064B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.063B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.061B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.059B	0.00
MiNK Therapeutics (INKT)	United States	$0.055B	0.00
Precision BioSciences (DTIL)	United States	$0.055B	0.00
Grace Therapeutics (GRCE)	United States	$0.055B	0.00
ABVC BioPharma (ABVC)	United States	$0.052B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.052B	0.00
Clene (CLNN)	United States	$0.051B	0.00
IBio (IBIO)	United States	$0.050B	0.00
Aligos Therapeutics (ALGS)	United States	$0.049B	0.00
Q32 Bio (QTTB)	United States	$0.048B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
NextCure (NXTC)	United States	$0.047B	0.00
PDS Biotechnology (PDSB)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.045B	0.00
Galecto (GLTO)	Denmark	$0.045B	0.00
Cingulate (CING)	United States	$0.044B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.043B	0.00
Jasper Therapeutics (JSPR)	United States	$0.043B	0.00
INmune Bio (INMB)	United States	$0.043B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.041B	0.00
Passage Bio (PASG)	United States	$0.041B	0.00
OnKure Therapeutics (OKUR)	United States	$0.040B	0.00
Lantern Pharma (LTRN)	United States	$0.040B	0.00
Femasys (FEMY)	United States	$0.040B	0.00
Exicure (XCUR)	United States	$0.039B	0.00
RenovoRx (RNXT)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
TELA Bio (TELA)	United States	$0.038B	0.00
IO Biotech (IOBT)	Denmark	$0.037B	0.00
Elutia (ELUT)	United States	$0.036B	0.00
TuHURA Biosciences (HURA)	United States	$0.035B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.035B	0.00
Medicus Pharma (MDCX)	United States	$0.034B	0.00
Estrella Immunopharma (ESLA)	United States	$0.034B	0.00
Oncobiologics (OTLK)	United States	$0.033B	0.00
Xilio Therapeutics (XLO)	United States	$0.033B	0.00
AN2 Therapeutics (ANTX)	United States	$0.032B	0.00
Dyadic (DYAI)	United States	$0.032B	0.00
Rein Therapeutics (RNTX)	United States	$0.032B	0.00
Skye Bioscience (SKYE)	United States	$0.031B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.031B	1.98
Pluri (PLUR)	Israel	$0.031B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.029B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.029B	0.00
Senti Biosciences (SNTI)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Quantum Biopharma (QNTM)	Canada	$0.028B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.027B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
Rallybio (RLYB)	United States	$0.026B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.026B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.025B	0.00
Athira Pharma (LONA)	United States	$0.024B	0.00
Intensity Therapeutics (INTS)	United States	$0.024B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Hyperion DeFi (HYPD)	United States	$0.023B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.023B	0.00
Apollomics (APLM)	United States	$0.022B	0.00
Black Titan (BTTC)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
FibroBiologics (FBLG)	United States	$0.021B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
Lisata Therapeutics (LSTA)	United States	$0.019B	0.00
BioAtla (BCAB)	United States	$0.019B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.019B	0.00
Allarity Therapeutics (ALLR)	United States	$0.018B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.017B	0.00
Hoth Therapeutics (HOTH)	United States	$0.017B	0.00
Beyond Air (XAIR)	United States	$0.016B	0.00
Applied Therapeutics (APLT)	United States	$0.015B	0.00
Polyrizon (PLRZ)	Israel	$0.015B	0.00
Bionano Genomics (BNGO)	United States	$0.015B	0.00
Cocrystal Pharma (COCP)	United States	$0.014B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
BioCardia (BCDA)	United States	$0.014B	0.00
Curis (CRIS)	United States	$0.013B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.012B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.012B	0.00
Novogen (KZIA)	Australia	$0.012B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
NewcelX (NCEL)	Switzerland	$0.011B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.010B	0.00
IN8bio (INAB)	United States	$0.010B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Gelteq (GELS)	Australia	$0.010B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.010B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
GENPREX (GNPX)	United States	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Abpro Holdings (ABP)	United States	$0.008B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.008B	0.00
IMMURON (IMRN)	Australia	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
Advanced Biomed (ADVB)	United States	$0.007B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
MetaVia (MTVA)	United States	$0.007B	0.00
Synlogic (SYBX)	United States	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
KALA BIO (KALA)	United States	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Revelation Biosciences (REVB)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.005B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.005B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
Avalon GloboCare (ALBT)	United States	$0.005B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.005B	0.00
HCW Biologics (HCWB)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
GeoVax Labs (GOVX)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
Psyence Biomedical (PBM)	Canada	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00